Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias
Journal of Clinical Investigation · 17.03.2025 · 135 (6)
DOI: 10.1172/jci179137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 04.02.2025. Verfasst von Tanvi Potluri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Hernia, Inguinal, Fibroblasts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RRD VA, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Fibrosis of the lower abdominal muscle (LAM) contributes to muscle weakening and inguinal hernia formation, an ailment that affects a noteworthy 50% of men by age 75 and necessitates surgical correction as the singular therapy. Despite its prevalence, the mechanisms driving LAM fibrosis and hernia development remain poorly understood. Using a humanized mouse model that replicates the elevated skeletal muscle tissue estrogen concentrations seen in aging men, we identified estrogen receptor-α (ESR1) as a key driver of LAM fibroblast proliferation, extracellular matrix deposition, and hernia formation. Fibroblast-specific ESR1 ablation effectively prevented muscle fibrosis and herniation, while pharmacological ESR1 inhibition with fulvestrant reversed hernias and restored normal muscle architecture. Multiomics analyses of in vitro LAM fibroblasts from humanized mice unveiled an estrogen/ESR1-mediated activation of a distinct profibrotic cistrome and gene expression signature, concordant with observations in inguinal hernia tissues in human males. Our findings hold significant promise for prospective medical interventions targeting fibrotic conditions and present non-surgical avenues for addressing inguinal hernias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Surgery, McGovern Medical School at the University of Texas Health Sciences Center, Houston, Texas, USA.
- Department of Biomedical Engineering, University of Illinois Chicago, Chicago, Illinois, USA.
- Department of Pathology, Feinberg School of Medicine, and.
- Departments of Physical Medicine and Rehabilitation and Biomedical Engineering, Northwestern University, Chicago, Illinois, USA.
- Research Service, Hines VA Medical Center, Maywood, Illinois, USA.
Förderung
- RRD VA
- NIDDK NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- U.S. Department of Veterans Affairs
Zitieren
APA
Potluri, T., You, T., Yin, P., Coon, J., Stulberg, J. J., Dai, Y., Escobar, D. J., Lieber, R. L., Zhao, H., & Bulun, S. E. (2025). Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci179137
Vancouver
Potluri T, You T, Yin P, Coon J, Stulberg JJ, Dai Y, et al. Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias. Journal of Clinical Investigation. 2025;135(6). doi:10.1172/jci179137
BibTeX
@article{Potluri2025,
author = {Potluri, Tanvi and You, Tianming and Yin, Ping and Coon, John and Stulberg, Jonah J and Dai, Yang and Escobar, David J and Lieber, Richard L and Zhao, Hong and Bulun, Serdar E},
title = {Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {6},
doi = {10.1172/jci179137}
}
EUVIMED